These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33990705)

  • 1. Myeloid/lymphoid neoplasms with FLT3 rearrangement.
    Tang G; Tam W; Short NJ; Bose P; Wu D; Hurwitz SN; Bagg A; Rogers HJ; Hsi ED; Quesada AE; Wang W; Miranda RN; Bueso-Ramos CE; Medeiros LJ; Nardi V; Hasserjian RP; Arber DA; Orazi A; Foucar K; Wang SA
    Mod Pathol; 2021 Sep; 34(9):1673-1685. PubMed ID: 33990705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
    Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
    Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
    Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
    Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
    Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
    Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on eosinophilic disorders.
    Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
    Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
    Walz C; Erben P; Ritter M; Bloor A; Metzgeroth G; Telford N; Haferlach C; Haferlach T; Gesk S; Score J; Hofmann WK; Hochhaus A; Cross NC; Reiter A
    Blood; 2011 Aug; 118(8):2239-42. PubMed ID: 21705501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.
    Tang G; Sydney Sir Philip JK; Weinberg O; Tam W; Sadigh S; Lake JI; Margolskee EM; Rogers HJ; Miranda RN; Bueso-Ramos C C; Hsi ED; Orazi A; Hasserjian RP; Arber DA; Bagg A; Wang SA
    Mod Pathol; 2019 Apr; 32(4):490-498. PubMed ID: 30401948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
    Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
    Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML.
    Spitzer B; Dela Cruz FS; Ibanez Sanchez GD; Zhang Y; Xiao W; Benayed R; Markova A; Rodriguez-Sanchez MI; Bouvier N; Roshal M; Kung AL; Shukla N
    Blood Adv; 2021 Apr; 5(7):1899-1902. PubMed ID: 33792628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
    Saft L; Kvasnicka HM; Boudova L; Gianelli U; Lazzi S; Rozman M
    Histopathology; 2023 Dec; 83(6):829-849. PubMed ID: 37551450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms.
    Fang H; Tang G; Loghavi S; Greipp P; Wang W; Verstovsek S; Medeiros LJ; Reichard KK; Miranda RN; Wang SA
    Histopathology; 2020 Jun; 76(7):1042-1054. PubMed ID: 32083752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two myeloid leukemia cases with rare
    Zhang H; Paliga A; Hobbs E; Moore S; Olson S; Long N; Dao KT; Tyner JW
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].
    Zhou JR; Zhang X; Zhao YL; Yang JF; Zhang JP; Cao XY; Lu Y; Liu DY; Lyu FY; Ouyang J; Lu PH
    Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):751-756. PubMed ID: 30369187
    [No Abstract]   [Full Text] [Related]  

  • 17. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
    Gerds AT; Gotlib J; Bose P; Deininger MW; Dunbar A; Elshoury A; George TI; Gojo I; Gundabolu K; Hexner E; Hobbs G; Jain T; Jamieson C; Kuykendall AT; McMahon B; Mohan SR; Oehler V; Oh S; Pardanani A; Podoltsev N; Ranheim E; Rein L; Salit R; Snyder DS; Stein BL; Talpaz M; Thota S; Vachhani P; Wadleigh M; Walsh K; Ward DC; Bergman MA; Sundar H
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1248-1269. PubMed ID: 32886902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Venable ER; Gagnon MF; Pitel BA; Palmer JM; Peterson JF; Baughn LB; Hoppman NL; Greipp PT; Ketterling RP; Patnaik MS; Kelemen K; Xu X
    Cold Spring Harb Mol Case Stud; 2023 Feb; 9(1):. PubMed ID: 36627146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of FLT3 gene mutation in hematologic malignancies and its clinical significance].
    Liu H; Yu H; Jia HY; Zhang W; Guo CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):709-13. PubMed ID: 17708788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.